Skip to main content
. 2024 Mar 27;8(3):102390. doi: 10.1016/j.rpth.2024.102390

Table 6.

Incidence rates per 10,000 person-years and incidence rate ratios of venous thrombosis within all switchers vs all starters of combined oral contraceptives by follow-up duration in the Netherlands.

N of starters N of VT events among starters Person-years among starters IR of VT (per 10,000 person-years) in starters
(95% CI)
N of switchers N of VT events among switchers Person-years among switchers IR of VT (per 10,000 person-years) in switchers
(95% CI)
IRR (95% CI) among switchers vs starters (ref.) aIRRa (95% CI) among switchers vs starters (ref.)
Follow-up duration
1-3 9,851,084 739 1,204,535 6.14 (5.69-6.58) 450,748 30 36,215 8.28 (5.32-11.25) 1.35 (1.26-1.45) 1.77 (1.22-2.56)
4-6 11,494,639 547 910,875 6.01 (5.50-6.51) 347,721 18 28,061 6.41 (3.45-9.38) 1.07 (0.95-1.20) 1.20 (0.74-1.93)
7-9 8,360,085 423 666,169 6.35 (5.74-6.95) 303,168 8 24,380 3.28 (1.01-5.56) 0.52 (0.40-0.66) 0.58 (0.29-1.17)
10-12 7,013,938 296 579,853 5.10 (4.52-5.69) 266,814 14 22,585 6.20 (2.95-9.45) 1.21 (1.05-1.41) 1.43 (0.83-2.48)

aIRR, adjusted incidence rate ratio; IR, incidence rate; IRR, incidence rate ratio; N, number; VT, venous thrombosis; Ref., reference.

a

Adjusted for age and type of combined oral contraceptives.